Adjuvant therapy for stage I and II non-small cell lung cancer

被引:1
作者
Dorr, VJ
Perry, MC
机构
[1] Div. of Hematology/Medical Oncology, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO 65203
关键词
D O I
10.1016/S0889-8588(05)70430-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Even after curative resection, the overall 5-year survival rate for stage I and II non-small cell lung cancer remains less than optimal. In an attempt to improve survival, adjuvant therapy after curative resection has been evaluated. Chemotherapy, immunotherapy, radiotherapy, and various combinations of these have been investigated as means to improve survival. This article reviews these studies. At this time, adjuvant therapy remains investigational and its use should be limited to clinical trials.
引用
收藏
页码:267 / +
页数:1
相关论文
共 50 条
[1]   Adjuvant Therapy for Stage I and II Non-Small Cell Lung Cancer [J].
Naylor, Evan C. .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) :585-+
[2]   Therapy for stage I and stage II non-small cell lung cancer [J].
Tanoue, LT ;
Ponn, RB .
CLINICS IN CHEST MEDICINE, 2002, 23 (01) :173-+
[3]   Operation and adjuvant therapy of non-small cell lung cancer (Stage I to operable IIIA) [J].
Eberhardt, Wilfried ;
Fietkau, Rainer ;
Griesinger, Frank ;
Passlick, Bernward ;
Stuschke, Martin .
ONKOLOGIE, 2006, 29 :7-10
[4]   Radiation therapy of stage I and II non-small cell lung cancer (NSCLC) [J].
Zierhut, D ;
Bettscheider, C ;
Schubert, K ;
van Kampen, M ;
Wannenmacher, M .
LUNG CANCER, 2001, 34 :S39-S43
[5]   Radiation Therapy for Early Stage (I/II) Non-Small Cell Lung Cancer [J].
Jeremic, Branislav ;
Casas, Francesc ;
Wang, Luhua ;
Perin, Branislav .
CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 :87-93
[6]   Hypofractionated Radiation Therapy for Stage I and II Non-small Cell Lung Cancer [J].
Kuremsky, J. G. ;
Petty, W. J. ;
Miller, A. ;
Hinson, W. H. ;
Hampton, C. J. ;
Blackstock, A. W. ;
Urbanic, J. J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03) :S153-S154
[7]   The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer [J].
Horn, Leora ;
Sandler, Alan B. ;
Putnam, Joe B., Jr. ;
Johnson, David H. .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) :377-383
[8]   Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer [J].
Serke, Monika .
CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 :135-144
[9]   Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer [J].
Pisters, KMW .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :23-28
[10]   Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer [J].
Watanabe, Shun-ichi ;
Nakagawa, Kazuo ;
Suzuki, Kenji ;
Takamochi, Kazuya ;
Ito, Hiroyuki ;
Okami, Jiro ;
Aokage, Keiju ;
Saji, Hisashi ;
Yoshioka, Hiroshige ;
Zenke, Yoshitaka ;
Aoki, Tadashi ;
Tsutani, Yasuhiro ;
Okada, Morihito .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) :1112-1118